Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for RLAY
| Stock Name | Relay Therapeutics Inc |
| Ticker | RLAY(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US75943R1023 |
Show aggregate RLAY holdings
News associated with RLAY
- Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $17.25 Consensus PT from Analysts
- Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the […] - 2025-08-27 02:54:54
- XTX Topco Ltd Purchases 20,161 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
- XTX Topco Ltd lifted its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 33.7% in the 1st quarter, HoldingsChannel.com reports. The fund owned 79,913 shares of the company’s stock after buying an additional 20,161 shares during the period. XTX Topco Ltd’s holdings in Relay Therapeutics were worth $209,000 as of its most recent […] - 2025-08-14 04:22:55
- Raymond James Financial Has Lowered Expectations for Relay Therapeutics (NASDAQ:RLAY) Stock Price
- Relay Therapeutics (NASDAQ:RLAY – Free Report) had its target price reduced by Raymond James Financial from $29.00 to $19.00 in a research report report published on Friday morning,Benzinga reports. Raymond James Financial currently has a strong-buy rating on the stock. RLAY has been the subject of several other research reports. Wells Fargo & Company started […] - 2025-08-11 03:50:57
- Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of “Moderate Buy” from Brokerages
- Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve research firms that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1-year […] - 2025-07-30 02:46:52
- Relay Therapeutics (NASDAQ:RLAY) versus Incannex Healthcare (NASDAQ:IXHL) Head-To-Head Review
- Incannex Healthcare (NASDAQ:IXHL – Get Free Report) and Relay Therapeutics (NASDAQ:RLAY – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Institutional & Insider Ownership 0.4% of Incannex […] - 2025-07-29 02:49:02
- DekaBank Deutsche Girozentrale Buys 8,937 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
- DekaBank Deutsche Girozentrale boosted its stake in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 14.9% during the 1st quarter, HoldingsChannel reports. The fund owned 68,937 shares of the company’s stock after purchasing an additional 8,937 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Relay Therapeutics were worth $181,000 at the end […] - 2025-07-15 06:23:59
- Analysts Set Relay Therapeutics, Inc. (NASDAQ:RLAY) Target Price at $17.67
- Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve ratings firms that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The […] - 2025-07-08 02:38:55
- Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $17.67 Average Price Target from Analysts
- Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twelve analysts that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month […] - 2025-06-13 02:32:49
- Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Holdings Boosted by Squarepoint Ops LLC
- Squarepoint Ops LLC boosted its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 535.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 162,588 shares of the company’s stock after purchasing an additional 137,020 shares during the quarter. Squarepoint Ops […] - 2025-06-03 05:38:55
- Northern Trust Corp Raises Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)
- Northern Trust Corp boosted its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 24.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,169,979 shares of the company’s stock after acquiring an additional 231,713 shares during the quarter. Northern Trust Corp’s holdings in Relay Therapeutics were worth $4,820,000 at the […] - 2025-05-22 04:22:54
- Graham Capital Management L.P. Acquires New Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)
- Graham Capital Management L.P. acquired a new stake in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 31,569 shares of the company’s stock, valued at approximately $130,000. A number of other large investors have also added to […] - 2025-05-20 05:10:52
- Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $17.67 Average PT from Brokerages
- Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twelve analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 12-month price target […] - 2025-05-19 02:30:55
- MetLife Investment Management LLC Acquires 16,477 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
- MetLife Investment Management LLC increased its holdings in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 28.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 74,166 shares of the company’s stock after buying an additional 16,477 shares during the quarter. MetLife Investment Management LLC’s holdings in Relay Therapeutics were worth $306,000 […] - 2025-05-08 04:56:55
- 189,046 Shares in Relay Therapeutics, Inc. (NASDAQ:RLAY) Purchased by Raymond James Financial Inc.
- Raymond James Financial Inc. acquired a new stake in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 189,046 shares of the company’s stock, valued at approximately $779,000. Other institutional investors also recently modified their holdings of the company. Barclays PLC lifted its position in shares […] - 2025-05-07 05:46:50
- Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Position Reduced by Wells Fargo & Company MN
- Wells Fargo & Company MN trimmed its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 45.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 71,425 shares of the company’s stock after selling 59,042 shares during the period. Wells Fargo & Company MN’s holdings in Relay Therapeutics were worth $294,000 as of […] - 2025-05-07 04:52:58
- Renaissance Technologies LLC Grows Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)
- Renaissance Technologies LLC grew its stake in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 130.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,549,190 shares of the company’s stock after buying an additional 878,095 shares during the […] - 2025-04-20 05:00:52
- JPMorgan Chase & Co. Reduces Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)
- JPMorgan Chase & Co. decreased its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 9.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,978,443 shares of the company’s stock after selling 539,073 shares during the period. JPMorgan Chase & […] - 2025-04-11 06:20:51
- American Century Companies Inc. Purchases 51,499 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
- American Century Companies Inc. increased its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 23.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 272,166 shares of the company’s stock after buying an additional 51,499 shares during the quarter. American Century Companies Inc.’s holdings in Relay Therapeutics were worth $1,121,000 at the […] - 2025-04-11 04:34:48
- Prudential Financial Inc. Buys 173,000 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
- Prudential Financial Inc. grew its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 45.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 549,645 shares of the company’s stock after acquiring an additional 173,000 shares during the quarter. Prudential Financial […] - 2025-04-04 04:37:00
- Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by Teacher Retirement System of Texas
- Teacher Retirement System of Texas grew its stake in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 19.5% in the fourth quarter, Holdings Channel reports. The fund owned 33,720 shares of the company’s stock after purchasing an additional 5,492 shares during the period. Teacher Retirement System of Texas’ holdings in Relay Therapeutics were worth $139,000 […] - 2025-04-03 04:54:50
- Cibc World Markets Corp Buys New Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)
- Cibc World Markets Corp purchased a new position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 11,388 shares of the company’s stock, valued at approximately $47,000. Several other large investors also recently bought and […] - 2025-03-28 06:18:47
- Bank of New York Mellon Corp Purchases 50,190 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
- Bank of New York Mellon Corp raised its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 18.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 328,897 shares of the company’s stock after acquiring an additional 50,190 shares […] - 2025-03-24 05:10:52
- Relay Therapeutics (NASDAQ:RLAY) vs. Kyverna Therapeutics (NASDAQ:KYTX) Financial Survey
- Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) and Relay Therapeutics (NASDAQ:RLAY – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends. Insider & Institutional Ownership 18.1% of Kyverna […] - 2025-03-21 03:51:04
- Los Angeles Capital Management LLC Acquires 20,880 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
- Los Angeles Capital Management LLC increased its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 65.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,770 shares of the company’s stock after purchasing an additional 20,880 shares during the period. […] - 2025-03-05 08:41:42
- Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by China Universal Asset Management Co. Ltd.
- China Universal Asset Management Co. Ltd. raised its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 37.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,491 shares of the company’s stock after purchasing an additional 9,740 shares […] - 2025-02-04 06:53:08
iShares MSCI World Small Cap UCITS ETF USD (Acc) RLAY holdings
| Date | Number of RLAY Shares Held | Base Market Value of RLAY Shares | Local Market Value of RLAY Shares | Change in RLAY Shares Held | Change in RLAY Base Value | Current Price per RLAY Share Held | Previous Price per RLAY Share Held |
|---|
| 2025-10-15 (Wednesday) | 113,691 | USD 751,498 | USD 751,498 | | | | |
| 2025-10-10 (Friday) | 112,968 | USD 734,292 | USD 734,292 | | | | |
| 2025-10-08 (Wednesday) | 112,968 | USD 690,234 | USD 690,234 | | | | |
| 2025-10-07 (Tuesday) | 112,968 | USD 658,603 | USD 658,603 | 488 | USD 29,840 | USD 5.83 | USD 5.59 |
| 2025-10-06 (Monday) | 112,480 | USD 628,763 | USD 628,763 | 0 | USD 12,373 | USD 5.59 | USD 5.48 |
| 2025-10-03 (Friday) | 112,480 | USD 616,390 | USD 616,390 | 0 | USD 29,244 | USD 5.48 | USD 5.22 |
| 2025-10-02 (Thursday) | 112,480 | USD 587,146 | USD 587,146 | 0 | USD -11,248 | USD 5.22 | USD 5.32 |
| 2025-10-01 (Wednesday) | 112,480 | USD 598,394 | USD 598,394 | 0 | USD 11,248 | USD 5.32 | USD 5.22 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of RLAY by Blackrock for IE00BF4RFH31
Show aggregate share trades of RLAY| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 488 | | | 5.830* | | 4.05 |
| 2025-09-08 | SELL | -1,008 | | | 4.060* | | 4.00 Profit of 4,034 on sale |
| 2025-08-15 | BUY | 500 | | | 3.540* | | 4.00 |
| 2025-07-29 | BUY | 494 | | | 3.620* | | 4.01 |
| 2025-07-14 | BUY | 1,008 | | | 3.560* | | 4.03 |
| 2025-06-30 | BUY | 1,016 | | | 3.460* | | 4.05 |
| 2025-06-25 | BUY | 1,518 | | | 3.260* | | 4.06 |
| 2025-06-20 | SELL | -258 | | | 3.190* | | 4.07 Profit of 1,051 on sale |
| 2025-06-12 | SELL | -2,064 | | | 3.450* | | 4.10 Profit of 8,469 on sale |
| 2025-06-02 | BUY | 792 | | | 3.180* | | 4.15 |
| 2025-05-28 | BUY | 528 | | | 2.950* | | 4.17 |
| 2025-05-14 | BUY | 258 | | | 2.770* | | 4.27 |
| 2025-05-13 | BUY | 516 | | | 2.830* | | 4.28 |
| 2025-05-07 | BUY | 774 | | | 2.950* | | 4.32 |
| 2025-04-28 | BUY | 255 | | | 3.260* | | 4.39 |
| 2025-04-16 | BUY | 3,458 | | | 2.610* | | 4.50 |
| 2025-04-14 | BUY | 532 | | | 2.570* | | 4.53 |
| 2025-04-08 | SELL | -532 | | | 2.000* | | 4.62 Profit of 2,457 on sale |
| 2025-04-04 | SELL | -532 | | | 2.000* | | 4.67 Profit of 2,484 on sale |
| 2025-03-28 | BUY | 2,650 | | | 2.720* | | 4.76 |
| 2025-03-12 | SELL | -522 | | | 3.660* | | 4.96 Profit of 2,591 on sale |
| 2025-03-04 | SELL | -518 | | | 3.190* | | 5.06 Profit of 2,623 on sale |
| 2025-02-26 | SELL | -1,016 | | | 3.750* | | 5.15 Profit of 5,232 on sale |
| 2025-02-13 | BUY | 265 | | | 3.960* | | 5.31 |
| 2025-02-12 | BUY | 1,044 | | | 3.760* | | 5.33 |
| 2025-01-27 | BUY | 249 | | | 4.720* | | 5.53 |
| 2025-01-23 | BUY | 250 | | | 4.890* | | 5.55 |
| 2024-12-09 | BUY | 9,288 | | | 4.700* | | 5.62 |
| 2024-12-04 | BUY | 506 | | | 4.390* | | 5.69 |
| 2024-12-03 | BUY | 756 | | | 4.390* | | 5.72 |
| 2024-11-19 | BUY | 1,500 | | | 4.800* | | 6.04 |
| 2024-11-18 | BUY | 494 | | | 4.890* | | 6.07 |
| 2024-11-12 | BUY | 964 | | | 5.940* | | 6.08 |
| 2024-11-11 | BUY | 241 | | | 6.160* | | 6.07 |
| 2024-11-11 | BUY | 241 | | | 6.160* | | 6.07 |
| 2024-11-07 | BUY | 1,195 | | | 6.140* | | 6.06 |
| 2024-11-07 | BUY | 1,195 | | | 6.140* | | 6.06 |
| 2024-10-23 | BUY | 472 | | | 6.300* | | 6.54 |
| 2024-10-23 | BUY | 472 | | | 6.300* | | 6.54 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of RLAY
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 144,620 | 1,200 | 397,051 | 36.4% |
| 2025-09-18 | 380,192 | 4,620 | 1,109,349 | 34.3% |
| 2025-09-17 | 128,405 | 1,740 | 456,014 | 28.2% |
| 2025-09-16 | 96,003 | 8,039 | 417,266 | 23.0% |
| 2025-09-15 | 764,733 | 0 | 1,088,958 | 70.2% |
| 2025-09-12 | 137,163 | 1,605 | 418,228 | 32.8% |
| 2025-09-11 | 188,124 | 0 | 352,285 | 53.4% |
| 2025-09-10 | 249,836 | 0 | 607,365 | 41.1% |
| 2025-09-09 | 167,895 | 0 | 300,910 | 55.8% |
| 2025-09-08 | 254,941 | 2,900 | 448,572 | 56.8% |
| 2025-09-05 | 351,688 | 1,300 | 645,601 | 54.5% |
| 2025-09-04 | 289,712 | 35,629 | 726,488 | 39.9% |
| 2025-09-03 | 494,561 | 0 | 1,086,099 | 45.5% |
| 2025-09-02 | 204,564 | 0 | 343,174 | 59.6% |
| 2025-08-29 | 129,525 | 0 | 343,959 | 37.7% |
| 2025-08-28 | 159,475 | 0 | 314,271 | 50.7% |
| 2025-08-27 | 70,508 | 0 | 152,821 | 46.1% |
| 2025-08-26 | 96,608 | 0 | 221,801 | 43.6% |
| 2025-08-25 | 78,317 | 0 | 174,186 | 45.0% |
| 2025-08-22 | 170,944 | 0 | 379,008 | 45.1% |
| 2025-08-21 | 103,790 | 0 | 303,936 | 34.1% |
| 2025-08-20 | 185,219 | 1,931 | 412,921 | 44.9% |
| 2025-08-19 | 184,996 | 0 | 365,722 | 50.6% |
| 2025-08-18 | 155,717 | 0 | 295,322 | 52.7% |
| 2025-08-15 | 183,595 | 177 | 459,021 | 40.0% |
| 2025-08-14 | 230,081 | 1 | 595,701 | 38.6% |
| 2025-08-13 | 105,029 | 5 | 440,976 | 23.8% |
| 2025-08-12 | 363,358 | 0 | 741,674 | 49.0% |
| 2025-08-11 | 225,550 | 13,820 | 751,354 | 30.0% |
| 2025-08-08 | 1,093,754 | 46,830 | 1,874,163 | 58.4% |
| 2025-08-07 | 227,486 | 0 | 436,978 | 52.1% |
| 2025-08-06 | 183,857 | 45 | 473,124 | 38.9% |
| 2025-08-05 | 102,276 | 16 | 324,674 | 31.5% |
| 2025-08-04 | 138,014 | 0 | 1,074,852 | 12.8% |
| 2025-08-01 | 158,963 | 0 | 1,364,035 | 11.7% |
| 2025-07-31 | 282,708 | 0 | 2,038,337 | 13.9% |
| 2025-07-30 | 123,973 | 0 | 514,807 | 24.1% |
| 2025-07-29 | 280,006 | 2,175 | 995,074 | 28.1% |
| 2025-07-28 | 513,962 | 1,351 | 1,169,000 | 44.0% |
| 2025-07-25 | 251,136 | 32 | 947,123 | 26.5% |
| 2025-07-24 | 1,719,273 | 174 | 3,236,369 | 53.1% |
| 2025-07-23 | 189,149 | 250 | 2,686,072 | 7.0% |
| 2025-07-22 | 175,994 | 2,000 | 857,917 | 20.5% |
| 2025-07-21 | 210,138 | 300 | 845,244 | 24.9% |
| 2025-07-18 | 124,716 | 157 | 728,170 | 17.1% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.